Jtc Employer Solutions Trustee LTD Xenetic Biosciences, Inc. Transaction History

Jtc Employer Solutions Trustee LTD

  • $1.53 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021
BUY
$1.57 - $2.45 $42,375 - $66,127
26,991 New
26,991 $55,000

About Xenetic Biosciences, Inc.

XBIO Quotes by TradingView
  • Ticker XBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,166,600
  • Market Cap $64.6M
  • Description
  • Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...
More about XBIO
Track This Portfolio

Track Jtc Employer Solutions Trustee LTD Portfolio

Follow Jtc Employer Solutions Trustee LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jtc Employer Solutions Trustee LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jtc Employer Solutions Trustee LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email